Dana-Farber Lank Center for Genitourinary Oncology shared a post on X:
“GU Research Digest for the week of February 8 – 14: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on http://pubmed.ncbi.nlm.nih.gov to read!”
Genitourinary/Immunotherapy/General
Renal
Authors: Mohammad Jad Moussa et al.

Authors: Andrew Dhawan et al.

BBOX1 restrains TBK1-mTORC1 oncogenic signaling in clear cell renal cell carcinoma.
Authors: Chengheng Liao, et al.

Bladder/Urothelial
Authors: Nadine Houédé et al.

Sacituzumab govitecan in advanced urothelial carcinoma: TROPICS- 04, a phase III randomized trial.
Authors: Thomas Powles et al.

Authors: Aung Naing et al.

Prostate
Authors: Louise Emmett L, et al.

Authors: Rachel R Xiang, et al.

Combination Therapies in Locally Advanced and Metastatic Hormone- sensitive Prostate Cancer.
Authors: Arun A. Azad et al.

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.
Authors: Takafumi N Yamaguchi et al.

Effective Treatment of Disseminated Prostate Cancer Using CD46- Targeted 225Ac Therapy.
Authors: Anil P Bidkar et al.

Authors: Daniel Magee et al.

Authors: Thomas J. Hoffmann et al.

Targeting ADAR1 with a small molecule for the treatment of prostate cancer.
Authors: Xiao Wang et al.
